DCC4780 |
Slp120701 |
Novel SphK2-selective inhibitor with improved half-life to 8 h in mice |
|
DCC4781 |
Slp7111228 |
Novel selective SphK1 inhibitor |
|
DCC4782 |
Slr080811 |
Novel SphK2-selective inhibitor |
|
DCC4783 |
Slupp-225 |
Novel efflux pump inhibitor (EPI) |
|
DCC4784 |
Slupp-417 |
Novel efflux pump inhibitor (EPI) |
|
DCC4785 |
Sm-130686 |
Potent, orally-active agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) and growth hormone secretagogue |
|
DCC4786 |
Sm-131 |
Novel Potent, Cell-Permeable, Conformationally Constrained Second Mitochondria Derived Activator of Caspase (Smac) Mimetic |
|
DCC4787 |
Sm-337 |
Non-peptidic Smac mimetic, binding to XIAP, cIAP-1 and cIAP-2 proteins with higher affinities in cell growth inhibition in the MDA-MB-231 cell line |
|
DCC4788 |
Sm4487 |
Novel potent and selective inhibitor of galactokinase (GALK1) |
|
DCC4789 |
Sma-12b |
Novel inhibitor of IL-1 |
|
DCC4790 |
Smac127 |
Proapoptotic and anti-inflammatory agent, inducing apoptosis by inhibiting apoptosis proteins (IAPs) |
|
DCC4791 |
Smapp1 |
Novel activator of PP1, inducing HIV-1 transcription, reactivation of latent HIV-1 in chronically infected cells, and CDK9 phosphorylation |
|
DCC4792 |
Smart-h |
Potent inhibitor of microtubule polymerization |
|
DCC4793 |
Smart-oh |
Potent inhibitor of microtubule polymerization |
|
DCC4794 |
Smases D Inhibitor-1 |
Novel inhibitor of Loxosceles sphingomyelinases D (SMases D) |
|
DCC4795 |
Smases D Inhibitor-5 |
Novel inhibitor of Loxosceles sphingomyelinases D (SMases D) |
|
DCC4796 |
Smcy 5.5 |
Fluorogenic fluorescent probe for imaging lipid droplets; suitable for use with two-photon microscopy |
|
DCC4797 |
Smdc818909 |
Novel Allosteric Inhibitor of p97 |
|
DCC4798 |
Smer10 |
Novel enhancer of the clearance of mutant aggregate-prone proteins by autophagy in mammalian cell models of Huntington's and Parkinson's disease, independent of rapamycin |
|
DCC4799 |
S-mgb-234 Bis-tfa Salt |
Novel strathclyde minor groove binder (S-MGB), curing animal African trypanosomiasis (AAT) |
|
DCC4800 |
smip001 |
Novel enhancer of the cyclin-dependent kinase (CDK) inhibitor p27(Kip) |
|
DCC4801 |
Smip2.1 |
Novel TLR2 agonist, promoting cross-presentation by mouse and human antigen presenting cells |
|
DCC4802 |
Smk-17 |
Novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor |
|
DCC4803 |
Sml-10-70-1 |
Selective, direct-acting covalent inhibitor of the K-Ras G12C mutant relative to wild-type Ras |
|
DCC4804 |
Sml-8-73-1 |
Novel Active Site Inhibitor of Oncogenic K-Ras G12C |
|
DCC4805 |
Smn2-stablizer-27 |
Novel Stablizer of Survival of Motor Neuron 2 (SMN2) , Post-Translationally Stablizing SMN Protein for the Treatment of Spinal Muscular Atrophy (SMA) |
|
DCC4806 |
Smn-c5 |
Novel specific splicing enhancer, targeting RNA for a specific splicing correction, recognizing the interface between U1 snRNP and the SMN2 E7 5ʹ SS, promoting the U1-C zinc finger RNA duplex binding activity |
|
DCC4807 |
Smt022357 |
Second-generation modulator of utrophin, increasing utrophin expression in skeletal, respiratory and cardiac muscles |
|
DCC4808 |
Smtp-7 |
Novel dual inhibitor of thrombolysis and soluble epoxide hydrolase |
|
DCC4809 |
Smurf1 Inhibitor 1 |
Novel Smurf1 inhibitor, promoting bone formation in mouse models of distinctive age-related osteoporosis |
|